Description

Introduction Gliempaflozin 3D 25 is a combination antidiabetic medicine containing empagliflozin 25 mg, sitagliptin 100 mg, and metformin hydrochloride 1000 mg. It is used to help manage blood glucose levels in adults with type 2 diabetes mellitus when combination therapy is prescribed by a healthcare professional. These three active ingredients work through different mechanisms to improve blood sugar control. Empagliflozin helps remove excess glucose through urine, sitagliptin supports incretin hormone activity, and metformin reduces glucose production in the liver. The medicine should be used alongside a balanced diet, regular exercise, and appropriate medical monitoring. Uses Gliempaflozin 3D 25 is primarily prescribed for managing type 2 diabetes mellitus. Its main uses include: Helping control elevated blood glucose levels. Supporting improvement in HbA1c, which measures average blood sugar over time. Providing combination therapy when other treatments do not achieve adequate glucose control. Supporting long-term diabetes management alongside lifestyle modifications. It is not intended to treat type 1 diabetes or diabetic ketoacidosis. A doctor determines whether this combination is suitable based on individual health needs. Benefits Gliempaflozin 3D 25 offers three complementary mechanisms for blood sugar management. Empagliflozin promotes urinary glucose excretion, sitagliptin helps regulate glucose-dependent insulin release, and metformin improves insulin sensitivity while reducing hepatic glucose production. Potential benefits include improved glycaemic control, support for achieving individual HbA1c targets, and convenience through a combination formulation. Empagliflozin may also support modest weight reduction in some patients. However, results vary, and the medicine does not replace healthy eating, physical activity, or regular medical consultations. Dosage The dosage of Gliempaflozin 3D 25 must be determined by a qualified healthcare professional. The appropriate regimen depends on kidney function, previous diabetes treatment, blood glucose levels, and the specific formulation. Take the medicine exactly as prescribed and follow the instructions on its packaging. Metformin-containing medicines are commonly taken with meals to reduce gastrointestinal discomfort, but timing depends on the formulation. Do not change the dose, double a missed dose, or combine it with other diabetes medicines without medical advice. Side Effects Possible side effects of Gliempaflozin 3D 25 include nausea, diarrhoea, stomach discomfort, increased urination, thirst, headache, and genital fungal infections. Urinary tract infections may also occur. Low blood sugar is more likely when the medicine is combined with insulin or sulfonylureas. Seek urgent medical attention for severe abdominal pain, persistent vomiting, difficulty breathing, or signs of a serious allergic reaction, as these may indicate a serious complication. Precautions and Warnings Inform your doctor about kidney problems, allergies, existing medical conditions, and other medicines you take. Maintain adequate hydration unless advised otherwise. Seek medical guidance during severe illness, dehydration, or before surgery, as temporary treatment interruption may be necessary. Discuss pregnancy and breastfeeding with your healthcare professional. Avoid excessive alcohol consumption because it may increase the risk of metformin-associated complications. Kidney function monitoring is essential, and symptoms of ketoacidosis require urgent evaluation even when blood glucose is not substantially elevated. Conclusion Gliempaflozin 3D 25 combines empagliflozin 25 mg, sitagliptin 100 mg, and metformin hydrochloride 1000 mg to support type 2 diabetes management. When appropriately prescribed, it may help improve blood sugar control through complementary mechanisms. Always consult a healthcare professional before starting treatment and follow the prescribed dosage and monitoring plan.